Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
Active, not recruiting · NCT05123131 · Registry updated 2025-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2025-07-08 | NCT05123131 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Trials Ireland | 26 |
| Dana-Farber Cancer Institute | 324 |
| Sanofi | 254 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aarhus University Hospital | Aarhus | Denmark | 77 |
| Beaumont Hospital | Dublin | Ireland | 24 |
| Mater Misericordiae University Hospital | Dublin | Ireland | 15 |
| St James's Hospital | Dublin | Ireland | 12 |
| University Hospital Waterford | Waterford | Ireland | 11 |